
|Articles|April 1, 2003
Type A Versus Type B
Author(s)Terry Troy
Rancho Mirage, Calif. -- A recent study rating the effects of botulinum toxin B in the treatment of hyperkinetic facial wrinkles showed that Myobloc is an effective treatment for interglabellar wrinkles. And while Myobloc showed some advantages over the more commonly used Botox (botulinum toxin A), the longevity of the treatment is about one or two weeks less, even at higher dosages.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clinicians Weigh Topical Sequencing and Escalation in Complex Atopic Dermatitis Cases
2
CSU With Biochemical C1 Inhibitor Deficiency: Case Report Raises Diagnostic Questions
3
Common Mistakes in Managing Hair Loss and Pigmentary Disorders
4
Sonelokimab Meets Primary End Point in Phase 3 Psoriatic Arthritis Trial
5











